Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T- and NK-cell immunotherapy susceptibility study in Ewing's sarcoma
NL-OMON31114Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Apr 2007
- Countries
- 1
01
Overview
Open-label trial in Ewing sarcoma and bone neoplasm (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Molecular mechanisms of directional migration, Recognition and elimination of Ewing sarcoma by T/NK cells and 3 more. Planned start Apr 2007; status: not yet recruiting.
02
Conditions
Ewing sarcomabone neoplasm
Beyond the preview
Go deeper on NL-OMON31114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31114.